Triglycerides

apolipoprotein C2 ; Homo sapiens







63 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33934596 Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL). 2021 May 26 3
2 34458211 Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III. 2021 1
3 34459127 Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway. 2021 Aug 1
4 31935511 Blood miR-1275 is associated with risk of ischemic stroke and inhibits macrophage foam cell formation by targeting ApoC2 gene. 2020 Mar 20 1
5 32332429 Apolipoprotein C-II: the re-emergence of a forgotten factor. 2020 Jun 4
6 32332431 Regulation of lipoprotein lipase-mediated lipolysis of triglycerides. 2020 Jun 1
7 32562799 ApoC2 deficiency elicits severe hypertriglyceridemia and spontaneous atherosclerosis: A rodent model rescued from neonatal death. 2020 Aug 1
8 32793115 Genetics of Hypertriglyceridemia. 2020 1
9 32802915 AAV-Mediated ApoC2 Gene Therapy: Reversal of Severe Hypertriglyceridemia and Rescue of Neonatal Death in ApoC2-Deficient Hamsters. 2020 Sep 11 2
10 30863636 Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice. 2019 2
11 29206648 Relationship between plasma protein S levels and apolipoprotein C-II in Japanese middle-aged obese women and young nonobese women. 2018 Jan 1
12 28107429 Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients. 2017 2
13 28314859 Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E. 2017 Jun 1
14 29100061 Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism. 2017 Dec 3
15 26756862 Impact of phosphatidylcholine liposomes on the compositional changes of VLDL during lipoprotein lipase (LPL)-mediated lipolysis. 2016 Feb 1
16 27206937 Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach. 2016 May-Jun 1
17 27378472 Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III. 2016 Aug 7
18 26026161 A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II. 2015 Jul 17 2
19 23470567 Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene. 2013 1
20 23990203 Association between urinary albumin excretion and low-density lipoprotein heterogeneity following treatment of type 2 diabetes patients with the dipeptidyl peptidase-4 inhibitor, vildagliptin: a pilot study. 2013 Dec 1
21 22262056 The role of CREB-H transcription factor in triglyceride metabolism. 2012 Apr 1
22 22304839 A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. 2012 Jul 2
23 22808166 STAT1 interacts with RXRα to upregulate ApoCII gene expression in macrophages. 2012 2
24 19302807 Increased effect of fucoidan on lipoprotein lipase secretion in adipocytes. 2009 Apr 10 1
25 18450649 ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study. 2008 Aug 1
26 21291744 Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndrome. 2008 Aug 2
27 16314153 Apolipoprotein C-II is a novel substrate for matrix metalloproteinases. 2006 Jan 6 1
28 16782082 Evaluation of new apolipoprotein C-II and apolipoprotein C-III automatized immunoturbidimetric kits. 2006 Sep 1
29 15559550 [Dyslipidaemia and its management after immunosuppressive treatment]. 2004 Jul-Aug 1
30 12678662 Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population: almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms. 2003 1
31 12799125 Indices related to apo CII and CIII serum concentrations and coronary heart disease: a case-control study. 2003 Jul 1
32 12855707 1,1'-bis(anilino)-4-,4'-bis(naphtalene)-8,8'-disulfonate acts as an inhibitor of lipoprotein lipase and competes for binding with apolipoprotein CII. 2003 Sep 26 1
33 11812765 Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: evidence for linkage of triglyceride levels to chromosome 19q. 2002 Feb 1
34 12079439 Association between serum apolipoprotein C(II) concentration and coronary heart disease. 2002 Jul 1
35 12517327 Concentrations of apolipoproteins E, C2, and C3 and lipid profile in preeclampsia. 2002 2
36 11286640 Genetic determinants of plasma triglycerides: impact of rare and common mutations. 2001 May 2
37 8647097 Construction and functional characterization of recombinant fusion proteins of human lipoprotein lipase and apolipoprotein CII. 1996 May 1 2
38 8847480 Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action. 1995 Dec 2
39 7815420 Apolipoprotein CII-Padova (Tyr37-->stop) as a cause of chylomicronaemia in an Italian kindred from Siculiana. 1994 Aug 1
40 8020477 Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat). 1994 Jun 1 1
41 8245727 Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins. 1993 Oct 1
42 8301229 Effects of albumin and apolipoprotein C-II on the acyl-chain specificity of lipoprotein lipase catalysis. 1993 Dec 1
43 8350216 Relationship between plasma triglycerides and apolipoprotein CII in infants during the first year of life. 1993 Jul 1
44 1451339 Lipids and apolipoproteins change during the progression of chronic renal failure. 1992 Nov 1
45 1452137 [Composition and distribution of lipid and apolipoprotein in plasma lipoproteins of endogenous hypertriglyceridemia]. 1992 Jun 1
46 1619390 Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. 1992 Jun 1
47 1804473 Capacity of high-density lipoprotein for donating apolipoproteins to fat particles in hypertriglyceridemia induced by fat infusion. 1991 Sep-Oct 1
48 2307668 Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. 1990 Mar 15 1
49 3411241 Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins. 1988 May 2
50 3944267 Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. 1986 Feb 2